Outcome of Board Meeting for the Half Year and Year Ended on 31st March,2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Patel Chem Specialities Ltd reported strong annual results for FY26 with revenue from operations growing 30.6% to ₹13,726.33 lakhs from ₹10,508.78 lakhs in FY25. Profit after tax increased 18.8% to ₹1,255.22 lakhs versus ₹1,056.52 lakhs previously. The company's EBITDA margin compressed slightly from 14.10% to 13.06%, though absolute EBITDA rose to ₹1,792.69 lakhs. The auditors issued an unmodified opinion confirming clean financials. The board also reviewed related party transactions involving entities controlled by Managing Director Bhupesh Patel and Whole-Time Director Anshu Patel, including purchases from Av Celllose Products and Patel Industries, sales to Patelchem North America Inc, and unsecured loans to directors. IPO funds of ₹5,880 lakhs raised in July 2025 were utilized with no deviations from stated objects.
Positive for shareholders as both revenue and profit showed strong double-digit growth. The unmodified audit opinion provides assurance on financial quality, though the margin compression warrants monitoring. Related party transactions with director-controlled entities were disclosed and approved by the audit committee.